Tag: IZERVAY

Geographic atrophy of the eye is a serious, progressive form of age-related macular degeneration (AMD) that can lead to irreversible vision loss. For many years, patients who asked “what is GA?” were told there was no effective treatment. Today, with FDA-approved therapies like Izervay are designed to slow disease progression, the responsibility falls on eye care professionals to identify geographic atrophy symptoms early and ensure patients enter the right care pathway. A clear referral process between optometrists and ophthalmologists is essential to deliver the best outcomes for patients with GA in eyes.

In this episode of the Four-Eyed Professor podcast, Dr. Chris Lievens and Dr. Jessica Steen discussed how to recognize GA, how to monitor its progression, and how to guide patients through treatment discussions. Optometrists are increasingly asked not only what IZERVAY is and what it is used for, but also practical questions about how an IZERVAY eye injection works and what patients should expect.

On this week's episode, the Defocus Media team discusses rewriting the geographic atrophy conversation with IZERVAY. Join us in an engaging podcast episode...

As optometrists, how do we look at geographic atrophy differently? Join us for an engaging and informative discussion with Dr. Jennifer Lyerly and Dr....